Amy L. O'Donnell MD
Amy L. O'Donnell
MD
Clinical Associate Professor
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Endocrinology, Diabetes and Metabolism
Education and Training:
- Fellowship, Internal Medicine, University of Michigan Medical Center (1991)
- Residency, Internal Medicine, University of Michigan Medical Center (1988)
- MD, Internal Medicine, University at Buffalo (1985)
- BA, Biology, Boston University (1981)
Employment:
- Clinical Associate Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2006-present)
- Chief of Endocrinology Division, VA WNY Healthcare System (1997-present)
- Attending Physician, VA WNY Healthcare System
- Clinical Assistant Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2001–2005)
- Research Assistant Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1992–2001)
- Chief, Endocrine and Diabetes Clinics, VA WNY Healthcare System (1995–1997)
- Lecturer/Research Fellow, University of Michigan Medical Center (1991–1992)
Journal Articles:
- Ali SH, O'donnell AL, Mohamed S, Mousa S, Dandona P. (2004) Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors. Gynecol Oncol (Dec), 95(3): 637-645.
- Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (Sep), 82(5): 322-332.
- Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. (2003) Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (Sep), 82(5): 333-339.
- Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P. (2001) High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors. Cell Prolif (Aug), 34(4): 223-231.
- Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P. (2000) Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res (Dec), 60(24): 7094-7098.
- Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P. (1999) Stable over-expression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor. Mol Cell Endocrinol (Jun), 152(1-2): 1-9.
- O'Donnell JL, O'Donnell AL, O‘Donnell AL. (1996) Prostaglandin E2 content in herniated lumbar disc disease. Spine (Phila Pa 1976) (Jul), 21(14): 1653-1655.
- O'Donnell AL, Letting DJ, DeRemer MF, Morse GD. (1994) Evidence of alkaline phosphatase interference in a zidovudine radioimmunoassay. Antimicrob Agents Chemother (Dec), 38(12): 2689-2694.
- Rosser LM, O‘Donnell AL, Lee KH, Morse GD. (1994) In vitro protein-binding characteristics of atevirdine and its N-dealkylated metabolite. Antiviral Res (Dec), 25(3-4): 193-200.
- Cordaro JA, Morse G, Bartos L, Gugino LJ, Maliszewski M, Colomaio R, Shelton M, O‘Donnell A, Hewitt R. (1993) Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle. Pharmacotherapy (Jul), 07(4): 369-377.
- Shelton MJ, O'Donnell AL, Morse GD. (1993) Zalcitabine. Ann Pharmacother (Apr), 27(4): 480-489.
- Morse GD, Shelton MJ, O'Donnell AL. (1993) Comparative pharmacokinetics of antiviral nucleoside analogues. Clin Pharmacokinet (Feb), 24(2): 101-123.
- Rosen ED, O'Donnell AL, Koenig RJ, O‘Donnell AL. (1992) Ligand-dependent synergy of thyroid hormone and retinoid X receptors. J Biol Chem (Nov), 267(31): 22010-22013.
- Shelton MJ, O'Donnell A, Morse GD. (1992) Didanosine. Ann Pharmacother (May), 26(5): 660-670.
- Rosen ED, O'Donnell AL, Koenig RJ, O‘Donnell AL. (1991) Protein-protein interactions involving erbA superfamily receptors: through the TRAPdoor. Mol Cell Endocrinol (Jun), 78(1-2): 83-88.
- O'Donnell AL, Rosen ED, Darling DS, Koenig RJ, O‘Donnell AL. (1991) Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein. Mol Endocrinol (Jan), 5(1): 94-99.
- O'Donnell AL, Koenig RJ, O‘Donnell AL. (1990) Mutational analysis identifies a new functional domain of the thyroid hormone receptor. Mol Endocrinol (May), 4(5): 715-720.
Professional Memberships:
- American Association of Clinical Endocrinologists; Member
- American Diabetes Association; Member
- The American Thyroid Association; Member
- The Endocrine Society; Member